ARCHIVES

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

This article is from The Cancer Letter archive.

Vol. 20 No. 43 | November 11, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says

August 11, 1995

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

December 11, 1987

PDQ Out of Business Of Setting Guidelines For Cancer Screening

September 17, 1993

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

RTOG Finds Twice A Day Radiation For Advanced Head And Neck Cancer Improved Local Tumor Control Rate

August 25, 2000